B

Blue Owl Capital Holdings LP Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Blue Owl Capital Holdings LP with $318.8M in long positions as of Q3 2025, 51% allocated to Healthcare, and 62% concentrated in top 10 positions.

Portfolio Value
$318.8M
Top 10 Concentration
62%
Top Sector
Healthcare (51%)
US Exposure
85%
Market Cap Focus
Small Cap
Countries
6

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 50.90%HealthcareFinancial Services: 22.70%Financial ServicesTechnology: 12.20%TechnologyConsumer Cyclical: 4.80%Industrials: 2.30%Energy: 0.30%
Healthcare
50.90%
Financial Services
22.70%
Technology
12.20%
Consumer Cyclical
4.80%
Industrials
2.30%
Energy
0.30%

Industry Breakdown

18 industries across all sectors

Biotechnology: 48.66%BiotechnologyAsset Management: 13.38%Asset ManagementFinancial - Credit Services: 8.19%Financial - Credit ServicesSoftware - Infrastructure: 5.74%Auto - Parts: 4.79%Information Technology Services: 3.91%12 more: 8.61%12 more
Biotechnology
Healthcare
48.66%
Asset Management
Financial Services
13.38%
Financial - Credit Services
Financial Services
8.19%
Software - Infrastructure
Technology
5.74%
Auto - Parts
Consumer Cyclical
4.79%
Information Technology Services
Technology
3.91%
Computer Hardware
Technology
2.33%
Specialty Business Services
Industrials
2.29%
Drug Manufacturers - Specialty & Generic
Healthcare
2.19%
Banks - Diversified
Financial Services
0.87%
Oil & Gas Midstream
Energy
0.31%
Software - Application
Technology
0.19%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 8.28%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 22.32%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 46.83%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 19.24%Micro Cap ($50M - $300M)Nano Cap (< $50M): 0.48%N/A (ETF or Unknown): 2.85%
Large Cap ($10B - $200B)
8.28%
Mid Cap ($2B - $10B)
22.32%
Small Cap ($300M - $2B)
46.83%
Micro Cap ($50M - $300M)
19.24%
Nano Cap (< $50M)
0.48%
N/A (ETF or Unknown)
2.85%

Portfolio Concentration

Top 10 Holdings %
62.31%
Top 20 Holdings %
84.61%
Top 50 Holdings %
99.96%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
84.58%
International
15.42%
Countries
6
Largest Int'l Market
Canada - 8.93%
United States of America
84.58% ($269.6M)
56 holdings
Canada
8.93% ($28.5M)
3 holdings
United Kingdom
4.69% ($15.0M)
1 holdings
Switzerland
0.92% ($2.9M)
1 holdings
Brazil
0.88% ($2.8M)
2 holdings
India
0.00% ($15.8K)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
6.1 quarters
Avg. Top 20
5.5 quarters
Avg. All Positions
3.7 quarters
Median Holding Period
4 quarters
Persistence Rate
56.25%
Persistent Holdings Weight
81.0%
Persistent Positions
36
Longest Held
ADC Therapeutics SA logo
ADC Therapeutics SAADCT - 12 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.84%
Avg. Position Weight
1.56%
Largest Position
Nuveen Churchill Direct Lending Corp logo
Nuveen Churchill Direct Lending CorpNCDL - 13.38%
Largest Ownership Stake
Context Therapeutics Inc. Common Stock logo
Context Therapeutics Inc. Common StockCNTX - 8.26%
Avg. Ownership Stake
3.12%
Ownership Stake >5%
5
Ownership Stake >1%
19

Historical (Since Q4 2021)

Avg. New Position
1.44%
Avg. Ownership Stake
10.09%
Largest Position
Blue Owl Capital Inc. logo
Blue Owl Capital Inc.OWL - 85.47% (Q4 2021)
Largest Ownership Stake
Blue Owl Capital Inc. logo
Blue Owl Capital Inc.OWL - 30.72% (Q4 2021)

Portfolio Turnover

Current Quarter

Turnover Ratio
23.2%
Value Traded
$73.85M
Positions Added
2
Positions Exited
8

Historical (Since Q4 2021)

Avg. Turnover Ratio
46.6%
Avg. Positions Added
13
Avg. Positions Exited
10
Highest Turnover
423.2%
Q1 2022
Lowest Turnover
5.4%
Q3 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.